Mainz Biomed (MYNZ) announced the first patient has been enrolled in eAArly DETECT 2, a feasibility study to evaluate the Company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback